CCL2 and diabetic kidney disease: The urinary microalbumin of T2DM patients consistently increased within a 6.5-year follow-up, with increasing serum and urinary MCP-1 levels, suggesting that MCP-1 may be a biomarker of early diabetic nephropathy (Ehses et al., 2009).